Research Roundup

Debbie Rigby rounds up the latest in research news Benefits and harms of intensive glycemic control in patients with type 2 diabetes The body of evidence shows no meaningful benefit of intensive (compared with moderate) glycemic control for microvascular and macrovascular outcomes important to patients, with the exception of reduced rates of non-fatal myocardial infarction.